Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 25, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - May 25, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 28     Next >>     Go To Page:

5/25/17 - AG Paxton, 42 States Reach $33 Million Settlement with Johnson & Johnson Regarding Quality of Over-Counter Drugs
Attorney General Ken Paxton today announced that Texas will receive more than $2.2 million in a $33 million, 43- state settlement with pharmaceutical company Johnson& Johnson. From 2009 to 2011, alleged quality control lapses by McNeil-PPC, Inc., a wholly-owned subsidiary of Johnson& Johnson, resulted in recalls of many over-the-counter drugs for a
5/25/17 - Hepatitis has been on the rise
Hepatitis has been on the rise in Swain County and other parts of the country. The rise of injection drug use in Swain County and the rest of the United States is linked to the spread of Hepatitis C. In Swain County, there is a high incidence of drug use both prescription and non-prescription drugs, and injection is becoming more common among those
5/25/17 - Innovus Pharma Launches AllerVarx, a Clinically Proven Supplement for the Relief of Allergy Symptoms, in the United States [Sport360]
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve mens and women`s health and respiratory diseases, today announced the launch of AllerVarx in the U.S. AllerVarx is a clinically proven supplement,...
5/24/17 - Attorney General Madigan, 42 Attorneys General Reach $33 Million Settlement with Johnson & Johnson Over Misrepresentation of Drug Quality
Attorney General Lisa Madigan and 42 other attorneys general today announced they have reached a $33 million settlement with Johnson& Johnson and its subsidiary over misrepresentations it made about manufacturing practices of well-known, over-the-counter drugs that resulted in recalls of products manufactured between 2009 and 2011, including...
5/24/17 - Drugmaker paying $33M over recalled nonprescription meds
Johnson& Johnson has reached a $33 million settlement with 42 states, resolving allegations the health care giant sold nonprescription medicines that didn't meet federal quality requirements. The case dates to 2009, when Johnson& Johnson began dozens of voluntary recalls of popular over-the-counter medicines for children and adults, including Ty
5/24/17 - GUEST COLUMN
Driving near Monterey, California, recently, I stopped at a roadside stand to buy some freshly picked strawberries. When I told him I work for Medicare, he said he was having difficulty paying for his prescription drugs. If you have Medicare and you're having trouble paying for prescription drugs, signing up for Medicare's Part D prescription drug
5/24/17 - HIA Comments on FTC Now Hear This Workshop and OTC Hearing Aids
The Hearing Industries Association (HIA) has issued a position paper in response to what the organization sees as several inaccurate statements made at the recent April 18 FTC Workshop titled, Now Hear This.
5/24/17 - How to lower your Medicare drug costs
Driving near Monterey, California, recently, I stopped at a roadside stand to buy some freshly picked strawberries. When I told him I work for Medicare, he said he was having difficulty paying for his prescription drugs. If you have Medicare and you're having trouble paying for prescription drugs, signing up for Medicare's Part D prescription drug
5/24/17 - Innovus Pharma Launches AllerVarx, a Clinically Proven Supplement for the Relief of Allergy Symptoms, in the United States
Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men s and women's health and respiratory diseases, today announced the launch of AllerVarx? in the U.S. AllerVarx? is a clinically proven supplement,..
5/24/17 - Myovant Sciences Announces Presentation of Data at the European Congress of Endocrinology from Phase 2 Extension Study Evaluating Relugolix in Women with Endometriosis-Associated Pain
Myovant Sciences today announced the presentation of data from a Phase 2 extension study conducted by Takeda Pharmaceutical Company Ltd. evaluating relugolix in Japanese women with endometriosis-associated pain. Oral, once-daily treatment with relugolix was generally well tolerated during the 24 weeks comprising the initial 12- week study and the
5/24/17 - Napo Pharmaceuticals New Mytesi Video Calls Attention to the Continuing Widespread Problem of Diarrhea in People Living With HIV/AIDS
Napo Pharmaceuticals, Inc., a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, which launched Mytesi in April, 2017, and Jaguar Animal Health, Inc., an animal health company which has licensed worldwide veterinary rights to Mytesi and is focuse
5/23/17 - DKSH and Boehringer Ingelheim improve access to treatment in Myanmar
DKSH and Boehringer Ingelheim improve access to treatment in Myanmar. DKSH, the leading Market Expansion Services provider with a focus on Asia, and Boehringer Ingelheim, one of the world's top 20 pharmaceutical companies, have signed an agreement to provide Myanmar patients better treatment options in vascular disease, arterial hypertension, cance
5/23/17 - Increasing Flurry of FDA Orphan Drug Development Activity Fueling Uptick of Enthusiasm for Few Pharma Stocks
The Health Care Sector which includes biotech, pharmaceutical and medical device stocks, continues to forge ahead despite recent concerns in the markets as some of the larger companies show attractive earnings growth potential all tied to new drug innovation, FDA approvals and device roll-outs. Health Care and Pharma stocks with developments and ma
5/23/17 - Medicare Q&A: Lower your Medicare drug costs
May is high season for California strawberries, and the fields were exploding with beautiful, ripe fruit. When I told him I work for Medicare, he said he was having difficulty paying for his prescription drugs. If you have Medicare and you're having trouble paying for prescription drugs, signing up for Medicare's Part D prescription drug coverage m
5/23/17 - Nutra Pharma Announces Collaboration with the International Security Group for Development of Nerve Agent Counter Measures
Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away? in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis, Human Immunodeficiency Virus, Adrenomyeloneuropathy and Pain, announced a collaboration today with International Security Group to develop its ner
5/23/17 - Sunovion Announces Utibron? Neohaler (indacaterol/glycopyrrolate) Inhalation Powder Data Showing Lung Function and Health-Related Quality of Life Improvement in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease
Sunovion Pharmaceuticals Inc. announced that multiple data analyses from two Phase 3 studies demonstrating that Utibron? Neohaler inhalation powder improved lung function, health-related quality of life, dyspnea and night-time symptoms compared to placebo in patients with moderate-to-severe chronic obstructive pulmonary disease, were...
5/22/17 - Bausch + Lomb Announces PDUFA Date For New OTC Redness Reliever, Brimonidine Tartrate Ophthalmic Solution, 0.025%
By a News Reporter-Staff News Editor at Pharma Business Week Valeant Pharmaceuticals International, Inc.' s wholly owned subsidiary, Bausch+ Lomb, a leading global eye health company, announced that the U.S. Food and Drug Administration accepted the New Drug Application for brimonidine tartrate ophthalmic solution, 0.025%, and set a PDUFA action
5/22/17 - Innovus Pharma Signs Exclusive License and Distribution Agreement with Luminarie in Australia, New Zealand and the Philippines for Zestra for Female Sexual Arousal Disorder and Zestra Glide for Female Lubrication
Innovus Pharmaceuticals, Inc., an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men s and women s health and vitality and respiratory diseases, announced today the si
5/22/17 - New Weighing Equipment Helps Pharmaceutical Company Pass the Audit Risk-Based Process Verification
For more than 200 years, the German-based company Klosterfrau Healthcare Group has been developing, manufacturing and selling pharmaceutical products. At its Berlin site, the company runs state-of-the-art production lines. The challenge for Claudia Brostmeyer, Head of Quality Control at the Berlin site, is to ensure that all workplaces with their v
5/22/17 - PERRIGO CO PLC - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013. We became the successor registrant to Perrigo Company, a Michigan corporation, on December 18, 2013 in connection with the acquisition of Elan Corporation, plc, which is discussed further in Item 8. Unless the context requires otherwise, the terms "Perrigo", the "Compa
5/22/17 - Sunovion Announces Positive Results from Study Evaluating Latuda (lurasidone HCl) in Children and Adolescents with Bipolar Depression at Annual American Psychiatric Association Meeting
Sunovion Pharmaceuticals Inc. today announced that results of a Phase 3 clinical study evaluating Latuda in children and adolescents with major depressive episodes associated with bipolar I disorder showed statistically significant and clinically meaningful improvement in depressive symptoms compared to placebo. The results were presented...
5/22/17 - U.S. FDA Accepts for Review Supplemental New Drug Application for Aptiom (eslicarbazepine acetate) for the Treatment of Partial-Onset Seizures in Children 4 to 17 Years of Age
The expected action date by the FDA under the Prescription Drug User Fee Act is September 13, 2017. We are pleased that the FDA has accepted our supplemental New Drug Application to potentially bring a new treatment option to children and adolescents who experience partial-onset seizures, said Antony Loebel, M.D., Executive Vice President and
5/19/17 - AAP Responds to FDA Reauthorization Act of 2017 as Passed by House Subcommittee
The American Academy of Pediatrics issued the following news release:. The FDA Reauthorization Act of 2017 passed today by the U.S. House of Representatives Energy and Commerce Health Subcommittee to reauthorize U.S. Food and Drug Administration user fees is a missed opportunity for children. The House vote comes one week after the U.S. Senate Comm
5/19/17 - Novartis receives positive CHMP opinion for first-line use of Zykadia in ALK-positive advanced non-small cell lung cancer (NSCLC)
Novartis International AG/ Novartis receives positive CHMP opinion for first-line use of Zykadia in ALK-positive advanced non-small cell lung cancer. *Phase III trial, first-line treatment with Zykadia resulted in improved progression-free survival over SOC chemotherapy with maintenance, including in patients with brain metastases* Zykadia is...
5/19/17 - Patent Issued for Method for Treatment of Acne Using Pharmaceutical Compositions of Clindamycin and Adapalene (USPTO 9636353)
By a News Reporter-Staff News Editor at Drug Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Mittal, Ravindra; Roy, Sunilendu Bhushan; Kothari, Jay Shantilal; Sheikh, Shafiq; Patel, Jitendra Dasharathlal; Pancholi, Jinesh Suresh, filed on October 19, 2011, was published online on May 2, 2017. The patent's
Articles(s): 1 - 25 of 28     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415